Literature DB >> 30540353

Factors Associated With Successful Medication Discontinuation After a Randomized Clinical Trial of Relapse Prevention in First-Episode Psychosis: A 10-Year Follow-up.

Christy L M Hui1, William G Honer2, Edwin H M Lee1, W C Chang1,3, Sherry K W Chan1,3, Eric Y H Chen1,3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30540353      PMCID： PMC6439735          DOI： 10.1001/jamapsychiatry.2018.3120

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  3 in total

Review 1.  Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.

Authors: 
Journal:  Int J Neuropsychopharmacol       Date:  2022-09-28       Impact factor: 5.678

2.  Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study.

Authors:  Jose M Rubio; Heidi Taipale; Antti Tanskanen; Christoph U Correll; John M Kane; Jari Tiihonen
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

3.  Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data.

Authors:  Georgios Schoretsanitis; John M Kane; Christoph U Correll; Jose M Rubio
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.